Tag: Weight Loss Surgery and Bariatric
No Weight Loss Benefit Seen for Neoadjuvant Semaglutide Before Weight Loss Surgery
No benefits seen in terms of weight loss, diabetes remission, surgery safety
At 10 Years, Roux-en-Y Gastric Bypass Superior for Patient Excess BMI Loss
However, sleeve gastrectomy and Roux-en-Y gastric bypass did not significantly differ in terms of mean percentage total weight loss
Metabolic Surgery May Be Beneficial in MASH-Related Cirrhosis, Obesity
Significantly lower 15-year cumulative incidence of major adverse liver outcomes seen in those undergoing metabolic surgery
Racial, Sex Disparities Seen in Discussion of, Progression to Weight Loss Surgery
Black patients equally likely to discuss, less likely to progress to metabolic and bariatric surgery than non-Black patients
Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in Surgeries
Authors say clinicians should evaluate trade-offs between pharmaceutical and surgical management of obesity
Metabolic-Bariatric Surgery Tied to Reduced Risk for Pancreatic Cancer in Those With Obesity
Reduced risk was more pronounced in those with type 2 diabetes, but was also seen in those without T2D
Metabolic Surgery Is Renoprotective in Patients With Obesity, CKD
Metabolic surgery linked to lower risk for progression of kidney impairment compared with GLP-1RA
Weight-Loss Surgery Benefits Blood Pressure Management
Benefits include remission and control of hypertension while cutting dependence on antihypertensive medications
Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea
Significantly lower risk of major adverse cardiovascular events, all-cause mortality seen in metabolic surgery group
Multimodal Antiobesity Medications Yield Superior Preoperative Weight Loss
Findings seen in high-risk patients with body mass index ≥70 preparing to undergo metabolic surgery